Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
City of Hope Medical Center
ImmunityBio, Inc.
Indaptus Therapeutics, Inc
Hoffmann-La Roche
Incyte Corporation
NeoTX Therapeutics Ltd.
City of Hope Medical Center
BioInvent International AB
Exelixis
Cancer Research UK
SOLTI Breast Cancer Research Group
Icahn School of Medicine at Mount Sinai
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
ImmunoVaccine Technologies, Inc. (IMV Inc.)